Jyong Biotech (MENS) Assets Average (2025)
Jyong Biotech (MENS) posted quarterly Assets Average of $29.2 million for Q4 2025, up 32.73% quarter-over-quarter from $22.0 million in Q2 2025.
Jyong Biotech (MENS) Assets Average (2025) Analysis & Trends
Jyong Biotech's Assets Average history runs 1 years deep, the most recent figure standing at $29.2 million for Q4 2025.
- In Q4 2025, Assets Average changed N/A year-over-year to $29.2 million; the TTM figure through Dec 2025 stood at $29.2 million (changed N/A YoY), while the FY2025 annual figure was $13.6 million, changed N/A from the prior year.
- Assets Average for Q4 2025 stood at $29.2 million, up from $22.0 million in the prior quarter.
- The five-year high for Assets Average was $29.2 million in Q4 2025, with the low at $22.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.34 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.09 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.27 Bn |
| 10 | Jyong Biotech | 157.70 Mn | 157.70 Mn | - | 29.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 29.22 Mn |
| Jun 30, 2025 | 22.02 Mn |